An Aib-His-D-2-Nal-D-Phe-Lys-NH2 pentapeptide that potently and selectively activates the growth hormone secretagogue receptor (GHS-R1a) in pituitary somatotroph cells to drive growth hormone release with a receptor selectivity profile that eliminates the prolactin and cortisol co-secretion characteristic of first-generation GH secretagogues including GHRP-6 and GHRP-2 and making it an indispensable research tool for studying GHS-R1a receptor pharmacology and Gq/11-calcium signal transduction, the structural determinants of GHS-R1a subtype selectivity separating GH release from prolactin and cortisol co-stimulation, pituitary somatotroph cell biology and selective GH secretory mechanisms, the complementary and synergistic regulation of GH release by GHRH and selective GHS-R1a agonists, IGF-1 axis downstream biology under selective GH stimulation, the comparative pharmacology of selective versus non-selective growth hormone secretagogues across the GHS-R1a agonist class, and the ghrelin axis biology of selective receptor engagement without the endocrine co-secretion confounds of first-generation GH secretagogue research, Researchers and institutions across Ireland can source verified, research-grade Ipamorelin directly from our Irish peptide supply, with domestic-speed dispatch and complete batch documentation

This study was designed to evaluate the prognostic significance of GLP1R expression across various cancer types, with the hypothesis that GLP1R expression might serve as an indicator of certain cancers sensitivity to glucagon/GLP-1 signaling
Tirzepatide pens are single-dose, single-use devices that should be discarded immediately after one injection
The beauty of ThermiSmooth is that it involves zero downtime and recovery
This information is incredibly useful for doctor visits, as it provides clear, objective data that can help your provider adjust your treatment plan
For more insights like this and to stay connected with the latest in peptide research, be sure to follow our work over on our Facebook page